About ME/CFS
Beta-Oxidation Transport Protocol

Acetyl-L-Carnitine vs. L-Carnitine: Fatty Acid Shuttling

Inner mitochondrial membrane translocase mechanics, central cholinergic synthesis, TMAO mitigation strategies, and an interactive carnitine subtype dosing engine for ME/CFS.

The Beta-Oxidation Block in Post-Viral Fatigue

Fatty acids are the body’s highest-yield ATP substrate (generating up to 106 ATP molecules per palmitate molecule vs. 32 ATP from glucose). However, long-chain fatty acids cannot diffuse across the inner mitochondrial membrane on their own; they require the carnitine palmitoyltransferase system (CPT-I, CACT, and CPT-II). When carnitine stores are depleted, beta-oxidation shuts down. Cells are forced into rapid glycolysis, creating profound muscle heaviness and rapid lactic acidosis upon minimal exertion PMID: 9449942.

Pharmacologic Comparison: ALCAR vs. L-Carnitine Fumarate

Choosing the right carnitine ester depends on whether the patient's primary disability is neuro-cognitive or peripheral muscular:

Clinical Parameter Acetyl-L-Carnitine (ALCAR) L-Carnitine Fumarate / Tartrate
Primary Target Tissue Central Nervous System & Brain. Crosses the blood-brain barrier via organic cation transporters. Skeletal Muscle & Myocardium. Concentrates in highly vascularized peripheral tissues.
Neurochemical Mechanism Donates acetyl groups to choline, directly fueling acetylcholine synthesis for memory, processing speed, and vagal tone. Delivers fumarate, a critical intermediate in the Krebs (TCA) cycle, accelerating oxidative ATP production in striated muscle.
Target Symptom Relief Brain fog, word-finding failure, cognitive PEM, executive fatigue, mental exhaustion. Lead-like muscle heaviness, post-exertional muscle soreness (PEMS), exercise intolerance, orthostatic fatigue.
Standard Therapeutic Dose 1,000 mg to 2,000 mg / day (Divided: 500–1,000 mg with breakfast and lunch). 1,000 mg to 3,000 mg / day (Divided with meals).
Insomnia / Overstimulation Risk High if taken late. Strongly activating; must be dosed before 1:00 PM. Low to moderate. Less central cholinergic stimulation.
TMAO Generation Risk Lower gut microbiome cleavage due to rapid upper GI absorption. Moderate; unabsorbed free carnitine can be metabolized by gut microbes into trimethylamine (TMA).
🧬

Carnitine Subtype & Beta-Oxidation Dosing Engine

Configure an evidence-based carnitine stack tailored to your primary fatigue phenotype, cognitive burden, and gastrointestinal tolerance.

ALCAR (Brain Fog)
1,000 mg / Day
L-Carnitine Fumarate
1,000 mg / Day
Dosing Schedule
Breakfast & Lunch
Latest Dosing Cutoff
1:00 PM (Strict)
Carnitine Clinical Regimen Exhibit 

      

    


    
    

      
Peer-Reviewed References & Clinical Sources

      
    
        
  1. 
          Kuratsune H, et al. Acylcarnitine deficiency in chronic fatigue syndrome. Clin Infect Dis. 1994;18(Suppl 1):S62-S67.
          PMID: 8148455
        
    2. 
        
  2. 
          Plioplys AV, Plioplys S. Amantadine and L-carnitine treatment of chronic fatigue syndrome. Neuropsychobiology. 1997;35(1):16-23.
          PMID: 9018735
        
    3. 
        
  3. 
          Vermeulen RC, Scholte HR. Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome. Psychosom Med. 2004;66(2):276-282.
          PMID: 15039515
        
    4. 
        
  4. 
          Koeth RA, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576-585.
          PMID: 23563705
        
    5.